Oral minoxidil 2.5 mg versus 5 mg for the treatment of male Pattern Hair Loss: a double-blind randomized clinical trial
Phase 2
Recruiting
- Conditions
- Androgenetic alopecia
- Registration Number
- RBR-6mjd8bx
- Lead Sponsor
- Faculdade de Medicina de Botucatu
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Male
- Target Recruitment
- Not specified
Inclusion Criteria
male; aged between 25 and 55 years; diagnosis of androgenetic alopecia; classified on the Norwood Hamilton scale as 3V, 4V or 5V; agreeing to participate in the research
Exclusion Criteria
previous treatment for hair loss in the last 4 months; hypertensive patients; patients with heart disease; nephropathy; hepatopathy; patients with pheochromocytoma; patients with other causes of hair loss or scalp dermatoses
Study & Design
- Study Type
- Intervention
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method